Safety and efficacy of Cerebrolysin in acute brain injury and neurorecovery: CAPTAIN I-a randomized, placebo-controlled, double-blind, Asian-Pacific trial.
W PoonC MatulaP E VosDafin F MuresanuN von SteinbüchelK von WildV HömbergE WangT M C LeeS StrilciucJ C VesterPublished in: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2019)
Our trial suggests beneficial effects of Cerebrolysin on outcome after TBI. Results should be confirmed by a larger RCT with a comparable multidimensional approach.
Keyphrases
- brain injury
- phase iii
- placebo controlled
- double blind
- phase ii
- study protocol
- clinical trial
- subarachnoid hemorrhage
- open label
- traumatic brain injury
- liver failure
- randomized controlled trial
- cerebral ischemia
- respiratory failure
- phase ii study
- radiation therapy
- hepatitis b virus
- squamous cell carcinoma
- intensive care unit
- severe traumatic brain injury
- drug induced
- blood brain barrier